Thought: Facebook ( NASDAQ:FB ) was down for few hours and was back shortly, but its stock was down since first day of IPO when it will be back? It touched $27, how much downside left or may be abyss..
Facebook's website suffered sporadic outages on Thursday (Friday in some time zones), anywhere from half an hour to two hours according to various blogs, tweets and affected users, but the company said the problem has been fixed.
"Earlier today, some users briefly experienced issues loading the site. The issues have since been resolved and everyone should now have access to Facebook," company spokesman Michael Kirkland told Reuters.
The outages came as Facebook continued to grapple with the fallout of its botched May 18 IPO. The stock has plummeted nearly 23 per cent from its IPO price, and numerous lawsuits have been filed in the wake of first-day trading glitches.
"Earlier today, some users briefly experienced issues loading the site. The issues have since been resolved and everyone should now have access to Facebook," company spokesman Michael Kirkland told Reuters.The outages came as Facebook continued to grapple with the fallout of its botched May 18 IPO. The stock has plummeted nearly 23 per cent from its IPO price, and numerous lawsuits have been filed in the wake of first-day trading glitches.
IBM And Honeywell's Barcode Scanning App Will Speed Up Your Grocery Run
Retailers big and small are cultivating a mobile-rich approach to their brick and mortar stores, rigging up their stores with swipe spots for your NFC-capable mobile wallet and replacing checkout tills with iPads. That change is bleeding into the pre-payment shopping experience as well. IBM and Honeywell just announced a new mobile app that lets customers scan and price their shopping as they pluck an item from the shop shelf and deposit it in their cart. The app is available for Android and iOS devices, and can scan any barcode on a product, "no matter what background it is printed on, the direction it faces, or the packaging covering it." The idea is, a customer can scan and check prices at will, then make a speedy exit through an IBM self-checkout station. (According to IBM research, self-checkouts themselves are hugely popular.) Coupons and promotions are included in the app, IBM says in a release.
Android APIs Safe In Google-Oracle Patent Fight
A California judge has ruled to cut Android out of the patent court battle between Google and Oracle. Oracle laid claim to Google's blockbuster mobile OS with charges that Google had violated rights to Oracle's Java APIs while creating Android. APIs, or application programming interfaces are bits of code that link different bits of software. Google's response was that an open source language cannot be patented--an argument a San Francisco judge agreed with. In a ruling, Judge Alsup (who learned to code in Java) decreed that the 37 APIs in question were free to use, though his ruling does not extend to other APIs.
Windows 8 Preview Hits, iPad-Challenging Tablets Coming In Its Wake
Microsoft has finally drawn the curtain on its public preview edition of Windows 8, it's next-generation operating system. This release is the final, near-complete preview of Win8 before its commercial release as a finished product, and gives Microsoft the chance to get the OS beta-tested by millions of people. Microsoft is counting on Win8 to ensure its future in the computing game, which has swung radically away from its traditional market with the boom in mobile computing and through innovations like the iPad. Acer, Toshiba, and Asus--all big-name PC makers usually aligned with Microsoft--are simultaneously said to be ready to reveal their Windows 8 tablets next week at the Computex show. Tablet sales will, MS hopes, win it a share of the booming mobile apps economy--said to be worth $58 billion.
Retailers big and small are cultivating a mobile-rich approach to their brick and mortar stores, rigging up their stores with swipe spots for your NFC-capable mobile wallet and replacing checkout tills with iPads. That change is bleeding into the pre-payment shopping experience as well. IBM and Honeywell just announced a new mobile app that lets customers scan and price their shopping as they pluck an item from the shop shelf and deposit it in their cart. The app is available for Android and iOS devices, and can scan any barcode on a product, "no matter what background it is printed on, the direction it faces, or the packaging covering it." The idea is, a customer can scan and check prices at will, then make a speedy exit through an IBM self-checkout station. (According to IBM research, self-checkouts themselves are hugely popular.) Coupons and promotions are included in the app, IBM says in a release.
Android APIs Safe In Google-Oracle Patent Fight
A California judge has ruled to cut Android out of the patent court battle between Google and Oracle. Oracle laid claim to Google's blockbuster mobile OS with charges that Google had violated rights to Oracle's Java APIs while creating Android. APIs, or application programming interfaces are bits of code that link different bits of software. Google's response was that an open source language cannot be patented--an argument a San Francisco judge agreed with. In a ruling, Judge Alsup (who learned to code in Java) decreed that the 37 APIs in question were free to use, though his ruling does not extend to other APIs.
Windows 8 Preview Hits, iPad-Challenging Tablets Coming In Its Wake
Microsoft has finally drawn the curtain on its public preview edition of Windows 8, it's next-generation operating system. This release is the final, near-complete preview of Win8 before its commercial release as a finished product, and gives Microsoft the chance to get the OS beta-tested by millions of people. Microsoft is counting on Win8 to ensure its future in the computing game, which has swung radically away from its traditional market with the boom in mobile computing and through innovations like the iPad. Acer, Toshiba, and Asus--all big-name PC makers usually aligned with Microsoft--are simultaneously said to be ready to reveal their Windows 8 tablets next week at the Computex show. Tablet sales will, MS hopes, win it a share of the booming mobile apps economy--said to be worth $58 billion.
• Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Actos Doubles Bladder CA Risk More...
• Positive Test Boosts Sanofi (France) (SAN.PA) MS Drug Hopes More...
• Veloxis Pharmaceuticals A/S (VELO) to Present Results from a Patient Subgroup Analysis of Once-Daily LCP-Tacro™ in Stable African-American Kidney Transplant Patients at American Transplant Congress More...
• Talon Therapeutics, Inc. (TLON.OB) Announces Enrollment and Dosing of the First Patient in the Phase 3 Confirmatory Study of Marqibo(R) in Adult Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia (HALLMARQ Study) More...
• UCB, Inc. (UCBJF.PK) to Showcase Broad Immunology Portfolio at EULAR2012 More...
• Johnson & Johnson (JNJ) Seeks Approval of Diabetes Pill More...
• Can a Decade of Dark Chocolate Protect Your Heart? Monash University Study More...
• Paralysed Rats Walk Again in Swiss Lab Study, Ecole Polytechnique Federale de Lausanne Reveals More...
• "Key Step" Closer to Universal Flu Vaccine, Emory University Study More...
• Autism May Diminish Belief in God, University of British Columbia Study More...
• Antioxidant Beta-Carotene Use Safe During Radiation Treatment for Prostate Cancer, Dana-Farber Cancer Institute Study More...
• Kythera Biopharmaceuticals Receives Notice of Allowance from U.S. Patent Office for Composition Claims Covering ATX-101 Active Ingredient More...
• NovaBay Pharmaceuticals, Inc. Strengthens Global Aganocide(R) Patent Estate With Seven New Patents More...
• Arcadia Biosciences, Inc. Receives Second Key Chinese Patent for Nitrogen Use Efficiency Technology More...
• UK's National Institute for Clinical Excellence (NICE) Recommends Johnson & Johnson (JNJ)'s Xarelto for Treating Blood Clots More...
• Marina Biotech, Inc. Runs Out of Cash, Axes 90 Pct. of Staff More...
• Sanofi (France) (SAN.PA) Aims to be Pharma's Top R&D Organization More...
• NicOx SA (COX.PA) Board Decides Not to Exercise its Option to Acquire the Remaining Shares of Altacor More...
• Forest Laboratories, Inc. (FRX) Coughs Up $25 Million for Nabriva Therapeutics's Phase II Antibacterial, Right to Take Over Company More...
• Boehringer Ingelheim Pharmaceuticals, Inc. and CancerCare® Launch My Cancer Circle™ Online Tool for Cancer Caregivers More...
• ACM Global Central Laboratory Appoints Mark Engelhartas Chief Commercial Officer More...
• PharmAthene, Inc. Release: Delaware Chancery Court Issues Final Order and Judgment Upholding Its Favorable Ruling More...
• Positive Test Boosts Sanofi (France) (SAN.PA) MS Drug Hopes More...
• Veloxis Pharmaceuticals A/S (VELO) to Present Results from a Patient Subgroup Analysis of Once-Daily LCP-Tacro™ in Stable African-American Kidney Transplant Patients at American Transplant Congress More...
• Talon Therapeutics, Inc. (TLON.OB) Announces Enrollment and Dosing of the First Patient in the Phase 3 Confirmatory Study of Marqibo(R) in Adult Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia (HALLMARQ Study) More...
• UCB, Inc. (UCBJF.PK) to Showcase Broad Immunology Portfolio at EULAR2012 More...
• Johnson & Johnson (JNJ) Seeks Approval of Diabetes Pill More...
• Can a Decade of Dark Chocolate Protect Your Heart? Monash University Study More...
• Paralysed Rats Walk Again in Swiss Lab Study, Ecole Polytechnique Federale de Lausanne Reveals More...
• "Key Step" Closer to Universal Flu Vaccine, Emory University Study More...
• Autism May Diminish Belief in God, University of British Columbia Study More...
• Antioxidant Beta-Carotene Use Safe During Radiation Treatment for Prostate Cancer, Dana-Farber Cancer Institute Study More...
• Kythera Biopharmaceuticals Receives Notice of Allowance from U.S. Patent Office for Composition Claims Covering ATX-101 Active Ingredient More...
• NovaBay Pharmaceuticals, Inc. Strengthens Global Aganocide(R) Patent Estate With Seven New Patents More...
• Arcadia Biosciences, Inc. Receives Second Key Chinese Patent for Nitrogen Use Efficiency Technology More...
• UK's National Institute for Clinical Excellence (NICE) Recommends Johnson & Johnson (JNJ)'s Xarelto for Treating Blood Clots More...
• Marina Biotech, Inc. Runs Out of Cash, Axes 90 Pct. of Staff More...
• Sanofi (France) (SAN.PA) Aims to be Pharma's Top R&D Organization More...
• NicOx SA (COX.PA) Board Decides Not to Exercise its Option to Acquire the Remaining Shares of Altacor More...
• Forest Laboratories, Inc. (FRX) Coughs Up $25 Million for Nabriva Therapeutics's Phase II Antibacterial, Right to Take Over Company More...
• Boehringer Ingelheim Pharmaceuticals, Inc. and CancerCare® Launch My Cancer Circle™ Online Tool for Cancer Caregivers More...
• ACM Global Central Laboratory Appoints Mark Engelhartas Chief Commercial Officer More...
• Changes in Siegfried Management More...
• Human Genome Sciences, Inc. (HGSI) Takeover Defense Survives Court Test More...
• Human Genome Sciences, Inc. (HGSI) Takeover Defense Survives Court Test More...
• PharmAthene, Inc. Release: Delaware Chancery Court Issues Final Order and Judgment Upholding Its Favorable Ruling More...
Global markets were under pressure due to the Spain debt worries and deadlock between European Union. Greek exit is also a focus for the market traders as next election to be held on june 17. If greece plans to exit euro, it will be catastrophic for markets and market might sell off. Meanwhile US economic indicators are loosing momentum and slipping added to more economic woes. Unemployment data is picking up in US and manufacturing dropped more than expected. Today's job data will clarify the picture, although no one is expecting any surprise on positive side, but if it comes on lower side of estimate, S&P will loose its important 1300 support level and another round of selling will start. S&P 500 is just holding up 1300 levels and bouncing back from the support. Watch out for those levels.
Nifty Trading Tips & Outlook Today
Our last call was buy on dips on Nifty as index has gained a momentum but unfortunately, it couldn't get above 5000 levels and stayed there. Selling pressure due to global uncertainty as well as worst GDP number for the quarter put a pressure on the markets and might see downgrades and revised earning targets for large caps. All these events lined up in next few days and might continue pressuring Nifty. Long positions squared off and one might look to short Nifty around 4980-5000 levels ( Spot ). The range for Nifty will be 4800-5000( Spot ) for next trading strategy. Trade accordingly
Check out our previous recommendation here
Nifty Trading Tips & Outlook Today
Our last call was buy on dips on Nifty as index has gained a momentum but unfortunately, it couldn't get above 5000 levels and stayed there. Selling pressure due to global uncertainty as well as worst GDP number for the quarter put a pressure on the markets and might see downgrades and revised earning targets for large caps. All these events lined up in next few days and might continue pressuring Nifty. Long positions squared off and one might look to short Nifty around 4980-5000 levels ( Spot ). The range for Nifty will be 4800-5000( Spot ) for next trading strategy. Trade accordingly
Check out our previous recommendation here
SpaceX Dragon Makes Fiery Re-entry, Watery Landing
SpaceX's Dragon capsule successfully undocked and deorbitted this morning after a historic launch and hookup with the International Space Station. The capsule completed its mission today, re-entering the Earth's atmosphere and splashing down in its general target area in the Pacific. (Elon Musk, SpaceX chief tweeted that the next version would "land with helicopter precison.") The craft was located after splashdown and is being recovered off the Baja Coast of California.
New Cyberweapon IXESHE Discovered
A new advanced persistent threat named IXESHE (pronounced I-Sushi) was recently discovered on the computer networks of Taiwanese electronics companies and several East Asian governments. The IXESHE campaign appears to have been underway since early 2009. According to a research paper by Trend Micro, IXESHE spread via infected PDF files that were sent to deliberately targeted employees. Once the APT infected a computer, the malware binary allowed unknown parties to remotely control and monitor operations. The spearphishing emails had titles such as "Discussion on Cross- Strait Maritime Cooperation," "The Obama Administration and the Middle East," and "China’s Charm Diplomacy in BRICS Summit."
Mobile News Reader Taptu Releases Web App Powered By HTML 5
News discovery and reader app Taptu just released a version of their reader app for the Web, powered by HTML5.
The web version of the news reader adds to Taptu's existing apps for iOS, Android, Nook, Blackberry and Kindle. Its creation was motivated by responses from its users, CEO Mitch Lazar told Fast Company. "Of all the requests we get regularly, the number one request has really been, 'Give us Taptu on the Web.'"
For Taptu, getting on the Web, is a break from tradition set by most newsreader apps, which tend to be mobile app focused, and in the case of Flipboard, only available on iOS devices. The Taptu Web app also prepares the company for a potential future in the versatile and cross-platform HTML5 as opposed to native apps. Though, for now, Taptu's focus won't stray too far from its mobile heritage. "If the market does move that way we'll be ready," Lazar said.
A little less like Flipboard, but a little more like Zite, Taptu's trump card is its search feature which throws up news stream suggestions based on word-search algorithms. Also, Taptu lets you "DJ your news" by mixing source streams within the app itself, as you might do with a Twitter list, or a Google Reader folder. Taptu is now porting those strengths to the desktop-accessible Web.
Up to 50 percent of Taptu's 800,000 readers are based in the U.S., home turf to other reader apps like Flipboard and Zite. 30 percent of Taptu's following is based in the company's base in the U.K.
ACTA Rejected In EU, As Google Faces Piracy Accusations
Today the Industry Committee, the Civil Liberties Committee and the Legal Affairs Committee of the European Parliament formally registered their recommendations to not sign the controversial Anti-Counterfeiting Trade Agreement ahead of a full EU vote in July.ArsTechnica points out it's the latest step in rejection of ACTA (which was designed by international bodies to protect assets of content creators with punitive measures, and ratified by President Obama in 2011), coming after national-level Dutch, Polish, German and Czech disapproval.
Meanwhile the RIAA has openly accused Google of failing to move dramatically against piracy-enabling websites linked through its search results, despite Google's recent moves to make its actions more clearly understood by adding Copyright Removal Requests to its Transparency Report. RIAA's EVP Brad Buckles has complained in a blog post that Google places "artificial limits on the number of queries that can be made by a copyright owner to identify infringements," and also "limits the number of links we can ask them to remove per day." The recording industry spokesbody is thus squarely blaming Google for merely linking to sites that then themselves link on to enable piracy of music.
Speaking at AllThingsD's D10 conference last night, Hollywood agent and head of William Morris Endeavor Agency Ari Emanuel made a number of controversial comments that similarly blamed Google for enabling piracy by not suppressing links to piracy-related search results. Faced with a question on the matter from The Verge's Josh Topolosky, Emanuel seemed confused and angered that this position was analagously compared to blaming the road a burglar drove down before burgling someone's house. Emanuel also point blank refused the notion that cable companies would unbundle content.
Earlier this month a study by North Carolina State University was the latest in a line of studies to show that piracy actually promotes sales of online content by showing torrented albums sold better than non-pirated peers. Also speaking at AllthingsD, Spotify's Daniel Ek noted that he expected his wildly successful online music streaming service, which generates reliable income for labels and may dissuade piracy due to its convenience and low cost, was blocked from entering the U.S. by inflexibility by record labels throughout a two and a half year process.
Cricket Wireless To Sell Pre-Paid iPhone Plans In The U.S.
Cricket Wireless has just become the first carrier to sell the iPhone in the U.S. as part of a pre-paid plan. Starting June 22, for $55 buyers of the iPhone 4 and iPhone 4S will have access to unlimited talk, texting, and data. The cost of the Cricket iPhone models are pegged at $150 less than the unlocked iPhone models sold by Apple, making it a sweeter deal for U.S. buyers reluctant to commit to one cellular network. While the Cricket pre-paid plan for the iPhone is a first for the U.S., pre-paid phones are much more common in international markets, which account for 60% of Apple's sales. Leap Wireless, which owns and sells phones though Cricket, has been selling phones of all kinds on pre-paid plans for about 10 years now, using a flat-rate, pre-paid, unlimited access model. Cricket also sells contractless access to broadband.
Virgin Galactic Space Crafts Get FAA Approval For Rocket-Powered Test Flight
The U.S. Federal Aviation Authority has granted Virgin Galactic's aircraft builder, Scaled, a permit to test launch vehicles using rocket motors. Two spacecrafts, the Spaceship Two and WhiteNightTwo have been approved to fly free, carrying the full weight of a rocket motor on board--the motor and craft have previously been tested independently. According to Virgin, Spaceship Two is the first human-carrying vehicle to receive such approval. This news comes just as another historic moment for private space flight winds down--over the last week,SpaceX's Dragon capsule successfully launched and docked with the ISS in spac, becoming the first privately built rocket to do so. As of this morning, Dragon has undocked and begun its journey back to Earth.
Online Advertising Rises Past 20% Of Ad Spending In Europe
The advertising industry seems somewhat resistant to the economic woes in Europe right now--it rose 0.8% in 2011. Online ads seem to be growing best with 14.5% year-on-year growth, while passing the €20 billion annual total for the first time. Considering that the entire European ad industry was worth about €100 billion in 2011, that means one in every five ads was seen online, with video ads being a particularly robust area of growth. The trend is likely to continue considering the growing integration of computing tech into daily lives, particularly when mobile, and may be one reason that Facebook is said to be working on a smartphone.
• Merck & Co., Inc. (MRK) CEO: We Will Not Follow Pfizer Inc. (PFE)'s Footsteps More...
• Vertex Pharmaceuticals (MA) (VRTX) Goes From Bad Data to a Bad Promotion More...
• 1 in 4 Medical Sales Job Seekers Forced into Job Search More...
• AssureRx Raises $12.5 Million Series C Financing More...
• GlaxoSmithKline (GSK) Eyes Replacing Human Genome Sciences, Inc. (HGSI) Board More...
• UCB, Inc. (UCBJF.PK) Takes Majority Stake in Brazil's Meizler More...
• Catalent Pharma Solutions Enters Agreement to Sell Its U.S. Commercial Packaging Operations More...
• AptarGroup to Expand Pharma Solutions Portfolio With the Acquisition of theStelmi Group, a Primary Packaging Components Maker More...
• GlaxoSmithKline (GSK)'s Stiefel Laboratories Pays Welichem Biotech Inc. (WBI.V) $50 Million for Topical Agent for Psoriasis, Atopic Dermatitis More...
• Bayer HealthCare (BAY), Covance Inc. (CVD) Ink Drug Development Pact More...
• Affymetrix (Santa Clara, California) (AFFX) and Leica Microsystems Announce Worldwide Collaboration on Automated, Single-Copy, RNA In Situ Hybridization (ISH) Tissue Assay for Research Use More...
• Icahn Takes Another Run at Forest Laboratories, Inc. (FRX) Board More...
• Polynoma Appoints John Chiplin, Ph.D., Chief Executive Officer More...
• Swedish Orphan Biovitrum Appoints Birgitte Volck as Chief Medical Officer More...
• Molecular Partners AG Strengthens Management Team With the Appointment of Lisa Rojkjaer, MD as Chief Medical Officer More...
• Zyngenia Appoints Frank Hsu, M.D., as Chief Medical Officer More...
• BioReference Laboratories, Inc. (BRLI) Announces Earnings Date for Second Quarter Fiscal Year 2012 More...
• GlaxoSmithKline (GSK) Partner Pronova BioPharma Wins Lovaza Patent Case Against Teva Pharmaceutical Industries Limited (TEVA) & Par Pharmaceutical, Inc. More...
• Pfizer Inc. (PFE) Cleared of Liability in Prempro Breast Cancer Case More...
• Change in Date of Anticipated Arbitration Decision in Sucampo Pharmaceuticals, Inc. Dispute More...
• Infectious Disease Research Institute (IDRI) Signs Lease with Alexandria Real Estate Equities, Inc. for New Seattle Headquarters More...
• Rockwell Medical Technologies (RMTI) Completes Patient Enrollment in CRUISE-1 Phase III Clinical Study More...
• AEterna Zentaris (AEZS): Article on Perifosine as Potential Novel Approach to the Treatment of Mesothelioma Published in Plos One More...
• A.P. Pharma, Inc. (APPA) Announces Study Finding Continuous Exposure to a 5-HT3 Antagonist Using APF530 Provides Better Emetic Control More...
• ImmunoCellular Therapeutics, Ltd to Present Long-term Survival Data from Clinical Study of ICT-107 in Glioblastoma Multiforme at American Society of Clinical Oncology Meeting More...
• Oregon Health & Science University (OHSU) Researchers Say Tart Cherries Have "the Highest Anti-Inflammatory Content of Any Food" More...
• Humans Can Sniff Out Old Age in Others, Monell Chemical Senses Center Study More...
• New Research Shows Runners Can Improve Health and Performance With Less Training, University of Copenhagen Study More...
• Exercise and a Healthy Diet of Fruits and Vegetables Extends Life Expectancy in Women in Their 70s, University of Michigan Study More...
• Ketamine Improved Bipolar Depression Within Minutes, National Institute of Mental Health Study More...
• La Jolla Pharmaceutical Company (LJPC) Announces Issuance of U.S. Patent Covering Modified Pectin Compositions More...
• Rhenovia Files Patents for New Treatment of Huntington's Disease Based on Its Innovative Biosimulation Platform More...
• Supplies of Maalox Dwindling Across Canada Caused by Novartis AG (NVS) Shutdown More...
• Pfizer Canada Inc. Release: New Personalized Medicine for ALK-positive Advanced or Metastatic Non-small Cell Lung Cancer More...
• Nouveau Life Pharmaceuticals (NOUV) Announces Release of Its Female Supplement More...
• Vertex Pharmaceuticals (MA) (VRTX) Goes From Bad Data to a Bad Promotion More...
• 1 in 4 Medical Sales Job Seekers Forced into Job Search More...
• AssureRx Raises $12.5 Million Series C Financing More...
• GlaxoSmithKline (GSK) Eyes Replacing Human Genome Sciences, Inc. (HGSI) Board More...
• UCB, Inc. (UCBJF.PK) Takes Majority Stake in Brazil's Meizler More...
• Catalent Pharma Solutions Enters Agreement to Sell Its U.S. Commercial Packaging Operations More...
• AptarGroup to Expand Pharma Solutions Portfolio With the Acquisition of theStelmi Group, a Primary Packaging Components Maker More...
• GlaxoSmithKline (GSK)'s Stiefel Laboratories Pays Welichem Biotech Inc. (WBI.V) $50 Million for Topical Agent for Psoriasis, Atopic Dermatitis More...
• Bayer HealthCare (BAY), Covance Inc. (CVD) Ink Drug Development Pact More...
• Affymetrix (Santa Clara, California) (AFFX) and Leica Microsystems Announce Worldwide Collaboration on Automated, Single-Copy, RNA In Situ Hybridization (ISH) Tissue Assay for Research Use More...
• Icahn Takes Another Run at Forest Laboratories, Inc. (FRX) Board More...
• Polynoma Appoints John Chiplin, Ph.D., Chief Executive Officer More...
• Swedish Orphan Biovitrum Appoints Birgitte Volck as Chief Medical Officer More...
• Molecular Partners AG Strengthens Management Team With the Appointment of Lisa Rojkjaer, MD as Chief Medical Officer More...
• Zyngenia Appoints Frank Hsu, M.D., as Chief Medical Officer More...
• BioReference Laboratories, Inc. (BRLI) Announces Earnings Date for Second Quarter Fiscal Year 2012 More...
• GlaxoSmithKline (GSK) Partner Pronova BioPharma Wins Lovaza Patent Case Against Teva Pharmaceutical Industries Limited (TEVA) & Par Pharmaceutical, Inc. More...
• Pfizer Inc. (PFE) Cleared of Liability in Prempro Breast Cancer Case More...
• Change in Date of Anticipated Arbitration Decision in Sucampo Pharmaceuticals, Inc. Dispute More...
• Infectious Disease Research Institute (IDRI) Signs Lease with Alexandria Real Estate Equities, Inc. for New Seattle Headquarters More...
• Chelsea Therapeutics, Inc. (CHTP) Plunges as RA Study Fails More...
• RXi Pharmaceuticals (RXII) Receives FDA Clearance to Begin Clinical Trial With RXI-109 More...
• Eli Lilly and Company (LLY) and Kowa Pharmaceuticals America Reveal Positive Results of PREVAIL US Study More...
• RXi Pharmaceuticals (RXII) Receives FDA Clearance to Begin Clinical Trial With RXI-109 More...
• Eli Lilly and Company (LLY) and Kowa Pharmaceuticals America Reveal Positive Results of PREVAIL US Study More...
• Rockwell Medical Technologies (RMTI) Completes Patient Enrollment in CRUISE-1 Phase III Clinical Study More...
• AEterna Zentaris (AEZS): Article on Perifosine as Potential Novel Approach to the Treatment of Mesothelioma Published in Plos One More...
• A.P. Pharma, Inc. (APPA) Announces Study Finding Continuous Exposure to a 5-HT3 Antagonist Using APF530 Provides Better Emetic Control More...
• ImmunoCellular Therapeutics, Ltd to Present Long-term Survival Data from Clinical Study of ICT-107 in Glioblastoma Multiforme at American Society of Clinical Oncology Meeting More...
• Oregon Health & Science University (OHSU) Researchers Say Tart Cherries Have "the Highest Anti-Inflammatory Content of Any Food" More...
• Humans Can Sniff Out Old Age in Others, Monell Chemical Senses Center Study More...
• New Research Shows Runners Can Improve Health and Performance With Less Training, University of Copenhagen Study More...
• Exercise and a Healthy Diet of Fruits and Vegetables Extends Life Expectancy in Women in Their 70s, University of Michigan Study More...
• Ketamine Improved Bipolar Depression Within Minutes, National Institute of Mental Health Study More...
• La Jolla Pharmaceutical Company (LJPC) Announces Issuance of U.S. Patent Covering Modified Pectin Compositions More...
• Rhenovia Files Patents for New Treatment of Huntington's Disease Based on Its Innovative Biosimulation Platform More...
• Supplies of Maalox Dwindling Across Canada Caused by Novartis AG (NVS) Shutdown More...
• Pfizer Canada Inc. Release: New Personalized Medicine for ALK-positive Advanced or Metastatic Non-small Cell Lung Cancer More...
• Nouveau Life Pharmaceuticals (NOUV) Announces Release of Its Female Supplement More...
Rozlyn Khan, another bollywood actress make a strip show for MS Dhoni after the Poonam Pandey.
As the headlines about Poonam pandey's nudity drama hasn't over yet, Another model cum actress Rozlyn Khan went topless to show loyalty to MS Dhoni and support Chennai Team. Is nudity only way to show support or cheer teams or there might be a publicity stunts? Most of the people who even doesn't heard the name of the model like Poonam Pandey or Rozlyn Khan might search Google for their nude pics. This might be a new trend to get focused by people and get noticed.
Google’s self-driving cars may be out on the road already, but it will take awhile before public is truly ready to give up all driving control to artificial intelligence. In the interim, Volvo has a solution that lets drivers (sometimes) sleep at the wheel while still improving highway safety--and it just completed the first real-world tests.
Dubbed SARTRE (Safe Road Trains for the Environment), the EU-backed project is working on road trains--vehicles equipped with software already found in many Volvo vehicles (including laser sensors, cameras, and radars) that are automatically led along the highway by a lead vehicle, which is commandeered by a professional driver. Regular drivers could one day simply use in-car navigation to find the nearest highway road train, get on the tail end, and let the vehicle platoon take over steering, braking, and acceleration.
Earlier this month, SARTRE let a road train loose on a highway in Spain (see video above). The train, which consisted of a Volvo XC60, a Volvo V60, a Volvo S60, a truck, and a lead vehicle, traveled at a respectable 53 mph. All the vehicles in the train copied the actions of the lead vehicle--including steering and braking--using wireless technology.
If unleashed en masse, these road trains could cut down on highway accidents, reduce traffic, and save fuel (since drivers aren’t constantly stopping and starting in traffic).
It’s hard to say when road trains will end up on a highway near you (Volvo hopes to have them on the road in Europe by 2020), who will hire people to drive the lead vehicles, or what happens if the lead driver makes some sort of error. But as Linda Wahlstrom, project manager of the SARTRE project, recently explained in a statement: "Apart from the software developed as part of the project, it is really only the wireless network installed between the cars that set them apart from other cars available in showrooms today."
Dubbed SARTRE (Safe Road Trains for the Environment), the EU-backed project is working on road trains--vehicles equipped with software already found in many Volvo vehicles (including laser sensors, cameras, and radars) that are automatically led along the highway by a lead vehicle, which is commandeered by a professional driver. Regular drivers could one day simply use in-car navigation to find the nearest highway road train, get on the tail end, and let the vehicle platoon take over steering, braking, and acceleration.
Earlier this month, SARTRE let a road train loose on a highway in Spain (see video above). The train, which consisted of a Volvo XC60, a Volvo V60, a Volvo S60, a truck, and a lead vehicle, traveled at a respectable 53 mph. All the vehicles in the train copied the actions of the lead vehicle--including steering and braking--using wireless technology.
If unleashed en masse, these road trains could cut down on highway accidents, reduce traffic, and save fuel (since drivers aren’t constantly stopping and starting in traffic).
It’s hard to say when road trains will end up on a highway near you (Volvo hopes to have them on the road in Europe by 2020), who will hire people to drive the lead vehicles, or what happens if the lead driver makes some sort of error. But as Linda Wahlstrom, project manager of the SARTRE project, recently explained in a statement: "Apart from the software developed as part of the project, it is really only the wireless network installed between the cars that set them apart from other cars available in showrooms today."
Aamir Khan was asked for apology for accusing doctors of malpractices in his TV talk show 'Satyamev Jayate'. Is he doing something wrong? If we see the highlights of the points in his fourth episode, it is mainly indicating what is actually happening in the society in more or less amount. He has tried to gather proofs and exposed them amongst general public. People who involved in pharmaceutical manufacturing or trading business knew better that everything shown in the episode was true. Doctors are getting different kind of perks from the pharmaceutical companies to promote their products. Pharmaceutical companies offers a foreign trip to some expensive gadgets, sometimes cash as well.
We have consulted few small business owners, who have started pharmaceutical business recently. If they want to promote their medicines, they need to offer some kind of perks or offers or sometimes cash commission. If doctor convinced with his share, then your product will be prescribed by doctors and pharmacy shop will sell it. The shocking thing is doctor's commission varies from 30% to 50 % of retailer price, which is very high. All the burden is included in MRP of the products as 30 % of doctors' commission and 30% of retailer's discount. Retailers' are doing business so he can ask for his margins, but doctors are charging fees to the patients and writing only those medicines, from which they get maximum commission irrespective of how much it will hurt to patients in terms of money. They want to get rich in any case. Big companies offers big perks like holiday trips and electronic gadgets. While small companies need to compete with big companies not in terms of quality but in terms of doctors' share. The end result is patients always suffering after paying higher cost for medicines and doctors' consulting fees.
India's growth story is slowly losing its sheen and has hit a three-year low with the GDP growing at just 6.5 per cent in 2011-12, as compared to an impressive 8.4 per cent in the previous fiscal. The GDP growth in the January-March quarter, 2011-12, was just 5.3 per cent compared to 9.2 per cent in the same period in 2010-11.
According to a CNBC-TV18 poll, the Q4 GDP was expected to be flat at around 6.1 per cent on a quarter-on-quarter (QoQ) basis. Fiscal deficit was estimated at 5.9 per cent.
Reflecting slowdown in the economy, the growth rate of eight infrastructure sectors slowed down to 2.2 per cent in April because of poor
performance of crude oil, natural gas, petroleum refinery products and fertilisers. The eight core sectors that also include coal, electricity, cement and finished steel, and have a weightage of 37.9 per cent in the Index of Industrial Production (IIP), had grown by 4.2 per cent in April 2011.
The cumulative growth rate of infrastructure industries during 2011-12 also slowed down to 4.4 per cent, from 6.6 per cent in 2010-11, according to the data released by the commerce and industry ministry on Thursday.
Natural gas and crude oil production contracted by 11.3 per cent and 1.3 per cent respectively during April. Petroleum refinery products and fertiliser production shrunk 2.8 per cent and 9.3 per cent respectively during the month.
Coal, Steel and cement output grew by 3.8 per cent, 5.8 per cent and 8.6 per cent in April 2012. In the same month last year, coal output had grown 2.7 per cent, steel - 2.9 per cent and cement - 0.1 per cent. However, electricity generation slowed down by 4.6 per cent, from 6.4 per cent in April 2011.
According to a CNBC-TV18 poll, the Q4 GDP was expected to be flat at around 6.1 per cent on a quarter-on-quarter (QoQ) basis. Fiscal deficit was estimated at 5.9 per cent.
Reflecting slowdown in the economy, the growth rate of eight infrastructure sectors slowed down to 2.2 per cent in April because of poor
performance of crude oil, natural gas, petroleum refinery products and fertilisers. The eight core sectors that also include coal, electricity, cement and finished steel, and have a weightage of 37.9 per cent in the Index of Industrial Production (IIP), had grown by 4.2 per cent in April 2011.
The cumulative growth rate of infrastructure industries during 2011-12 also slowed down to 4.4 per cent, from 6.6 per cent in 2010-11, according to the data released by the commerce and industry ministry on Thursday.
Natural gas and crude oil production contracted by 11.3 per cent and 1.3 per cent respectively during April. Petroleum refinery products and fertiliser production shrunk 2.8 per cent and 9.3 per cent respectively during the month.
Coal, Steel and cement output grew by 3.8 per cent, 5.8 per cent and 8.6 per cent in April 2012. In the same month last year, coal output had grown 2.7 per cent, steel - 2.9 per cent and cement - 0.1 per cent. However, electricity generation slowed down by 4.6 per cent, from 6.4 per cent in April 2011.



